Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 15.81 M14.96 M15.01 M18.97 M18.18 M17.92 M 70.08 M Research & development —————— — Operating income 11.94 M11.86 M11.69 M15.98 M-7.57 M27.29 M 47.39 M Non-Operating Income, Total 388 K434 K378 K507 K369 K437 K 1.69 M Interest expense, net of interest capitalized 11.73 M11.31 M11.39 M12.93 M12.13 M11.95 M 48.4 M Non-Operating Income, excl. Interest Expenses -11.35 M-10.88 M-11.01 M-12.42 M-11.77 M-11.51 M -46.71 M Unusual income/expense —————— — Pretax income 7.7 M7.53 M8.02 M5.39 M335 K17.43 M 31.17 M Equity in earnings —————— — Taxes 1.41 M1.42 M1.46 M926 K62 K3.37 M 5.82 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 6.29 M6.12 M6.55 M4.47 M273 K14.06 M 25.35 M Discontinued operations —————— — Net income 6.29 M6.12 M6.55 M4.47 M273 K14.06 M 25.35 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 6.24 M6.07 M6.5 M4.44 M273 K14.06 M 25.27 M Basic earnings per share (Basic EPS) 0.410.40.420.230.020.79 1.46 Diluted earnings per share (Diluted EPS) 0.410.40.420.280.020.79 1.51 Average basic shares outstanding 15.34 M15.36 M15.4 M15.95 M17.73 M17.77 M — Diluted shares outstanding 15.34 M15.36 M15.4 M15.95 M17.73 M17.75 M — EBITDA -377 K-925 K-296 K2.42 M-20.6 M13.73 M -4.75 M EBIT -930 K-1.49 M-857 K1.73 M-21.29 M13.04 M -7.38 M Cost of revenue 236 K2.35 M2.16 M1.32 M13.6 M-1.85 M 15.24 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 553 K562 K561 K687 K687 K689 K 2.62 M